Clinicopathological analysis of diffuse midline glioma, H3 K27M-mutant

被引：0
|
作者：
Kim, Seong-Ik [1 ]
Lee, Yujin [1 ]
Won, Jae Kyung [2 ]
Park, Sung-Hye [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
103
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [31] CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA
    Kawakibi, Abed Rahman
    Tarapore, Rohinton S.
    Gardner, Sharon
    Thomas, Chase
    Cartaxo, Rodrigo
    Yadav, Viveka Nand
    Chi, Andrew
    Kurz, Sylvia
    Wen, Patrick
    Arrillaga-Romany, Isabel
    Batchelor, Tracy
    Butowski, Nicholas
    Sumrall, Ashley
    Shonka, Nicole
    Harrison, Rebecca
    de Groot, John
    Mehta, Minesh
    Odia, Yazmin
    Hall, Matthew
    Daghistani, Doured
    Cloughesy, Timothy
    Ellingson, Benjamin
    Umemura, Yoshie
    Garton, Hugh
    Franson, Andrea
    Robertson, Patricia
    Schwartz, Jonathan
    Cantor, Evan
    Miklja, Zachary
    Mullan, Brendan
    Bruzek, Amy
    Siada, Ruby
    Cummings, Jessica
    Paul, Alyssa
    Wolfe, Ian
    Jiang, Li
    Filbin, Mariella
    Vats, Pankaj
    Kumar-Sinha, Chandan
    Mody, Rajen
    Chinnaiyan, Arul
    Venneti, Sriram
    Lu, Guangrong
    Mueller, Sabine
    Martinez, Daniel
    Resnick, Adam
    Nazarian, Javad
    Waszak, Sebastian
    Allen, Joshua
    Koschmann, Carl
    NEURO-ONCOLOGY, 2020, 22 : 45 - 46
  • [32] CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA PATIENTS
    Arrillaga-Romany, Isabel
    Kurz, Sylvia
    Tarapore, Rohinton
    Lu, Guangrong
    Sumrall, Ashley
    Butowski, Nicholas
    Harrison, Rebecca
    DeGroot, John
    Chi, Andrew
    Shonka, Nicole
    Umemura, Yoshie
    Odia, Yazmin
    Mehta, Minesh
    Nghiemphu, Phioanh
    Cloughesy, Timothy
    Taylor, Lynne
    Graber, Jerome
    Kilburn, Lindsay
    Dixit, Karan
    Chen, Clark
    Gardner, Sharon
    Aguilera, Dolly
    MacDonald, Tobey
    Cluster, Andrew
    Mehta, Kathan
    Kheradpour, Albert
    Melemed, Allen
    Allen, Joshua
    Batchelor, Tracy
    Lassman, Andrew
    Wen, Patrick
    NEURO-ONCOLOGY, 2021, 23 : 230 - 230
  • [33] H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
    Sachi Maeda
    Fumiharu Ohka
    Yusuke Okuno
    Kosuke Aoki
    Kazuya Motomura
    Kazuhito Takeuchi
    Hironao Kusakari
    Nobuyuki Yanagisawa
    Shinya Sato
    Junya Yamaguchi
    Kuniaki Tanahashi
    Masaki Hirano
    Akira Kato
    Hiroyuki Shimizu
    Yotaro Kitano
    Shintaro Yamazaki
    Shinji Yamashita
    Hideo Takeshima
    Keiko Shinjo
    Yutaka Kondo
    Toshihiko Wakabayashi
    Atsushi Natsume
    Acta Neuropathologica Communications, 8
  • [34] H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
    Maeda, Sachi
    Ohka, Fumiharu
    Okuno, Yusuke
    Aoki, Kosuke
    Motomura, Kazuya
    Takeuchi, Kazuhito
    Kusakari, Hironao
    Yanagisawa, Nobuyuki
    Sato, Shinya
    Yamaguchi, Junya
    Tanahashi, Kuniaki
    Hirano, Masaki
    Kato, Akira
    Shimizu, Hiroyuki
    Kitano, Yotaro
    Yamazaki, Shintaro
    Yamashita, Shinji
    Takeshima, Hideo
    Shinjo, Keiko
    Kondo, Yutaka
    Wakabayashi, Toshihiko
    Natsume, Atsushi
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [35] CLINICAL AND MOLECULAR CHARACTERIZATION OF ADULT DIFFUSE MIDLINE GLIOMAS, H3 K27M-MUTANT
    Grassl, N.
    Suwala, A.
    Kessler, T.
    Etminan, N.
    Unterberg, A.
    Breckwoldt, M.
    Bendszus, M.
    Groden, C.
    Debus, J.
    Ehmann, M.
    Wick, W.
    Sahm, F.
    Platten, M.
    Sahm, K.
    NEURO-ONCOLOGY, 2024, 26
  • [36] The prognosis of diffuse midline glioma H3 K27M mutant.
    Kim, Donghwan
    Chung, Chun Kee
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma-A Diagnostic Dilemma for the Pathologist
    Narasimhaiah, Deepti
    Thomas, Bejoy
    Abraham, Mathew
    Poyuran, Rajalakshmi
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2021, 12 (03) : 596 - 598
  • [38] H3 K27M-MUTANT DIFFUSE NON-MIDLINE GLIOMA: REPORT OF A CASE WITH EXTENDED FOLLOW-UP
    Donev, Kliment
    Sundararajan, Vanitha
    Johnson, Derek
    Ida, Cristiane
    NEURO-ONCOLOGY, 2021, 23 : 120 - 120
  • [39] Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma.
    Arrillaga, Isabel
    Kurz, Sylvia
    Sumrall, Ashley
    Butowski, Nicholas A.
    Harrison, Rebecca A.
    De Groot, John Frederick
    Shonka, Nicole A.
    Lieberman, Frank S.
    Odia, Yazmin
    Tarapore, Rohinton
    Merdinger, Krystal
    Allen, Joshua E.
    Oster, Wolfgang
    Mehta, Minesh P.
    Cloughesy, Timothy Francis
    Chi, Andrew S.
    Lassman, Andrew B.
    Batchelor, Tracy
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Response to ONC201 by Prior Radiotherapy Regimen in Recurrent H3 K27M-Mutant Diffuse Midline Glioma
    Arrillaga-Romany, I.
    McGovern, S. L.
    Allen, J. E.
    Gardner, S.
    Haggiagi, A. M.
    Odia, Y.
    Ramage, S. C.
    Wen, P. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E215 - E216
12345